Ivan Cheung, Eisai’s retiring US chair, global Alzheimer’s leader

Ei­sai’s US chair, glob­al Alzheimer’s leader to re­tire weeks af­ter Leqem­bi ap­proval

Ivan Che­ung, the glob­al leader of Ei­sai’s Alzheimer’s ap­pa­ra­tus, will re­tire at the end of Ju­ly, the Japan­ese drug­mak­er said Tues­day, just four days af­ter the biotech and its part­ner Bio­gen se­cured full ap­proval for Leqem­bi.

Tak­ing his place is Ei­sai CEO Haruo Naito’s son Keisuke Naito, who will add the act­ing glob­al Alzheimer’s post to his ex­ist­ing du­ties as chief strat­e­gy and plan­ning of­fi­cer and chief ecosys­tem of­fi­cer.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.